Chain length affects pancreatic lipase activity and the extent and pH-time profile of triglyceride lipolysis.

作者: Paloma Benito-Gallo , Alessandro Franceschetto , Jonathan C.M. Wong , Maria Marlow , Vanessa Zann

DOI: 10.1016/J.EJPB.2015.04.027

关键词: BioavailabilityHydrolysisBiochemistryTriglycerideMonoglycerideChromatographySolubilityFatty acidMicelleLipolysisChemistry

摘要: Triglycerides (TG) are one of the most common excipients used in oral lipid-based formulations. The chain length TG plays an important role bioavailability co-administered drug. Fatty acid (FA) chain-length specificity porcine pancreatic lipase was studied by means vitro lipolysis model under bio-relevant conditions at pH 6.80. In order to determine total extent lipolysis, back-titration experiments 11.50 were performed. Results suggest that there is a specific range (C2–C8) for which shows higher activity. This could result from combination physicochemical properties TGs, 2-monoglycerides (2-MGs) and FAs, namely droplet size solubility 2-MGs within mixed micelles, relative stability FAs as leaving groups hydrolysis reaction. During experimentation, it evident optimisation needed tighter control over levels so better mimic vivo conditions. 1 M NaOH, 3.5 mL/min maximum dosing rate, 3 μL/min minimum rate optimised set allowed control, well differentiation different lipid loads.

参考文章(62)
Niels Hønberg Zangenberg, Anette Müllertz, Henning Gjelstrup Kristensen, Lars Hovgaard, A dynamic in vitro lipolysis model. II: Evaluation of the model. European Journal of Pharmaceutical Sciences. ,vol. 14, pp. 237- 244 ,(2001) , 10.1016/S0928-0987(01)00182-8
Hans Lengsfeld, Gabrielle Beaumier-Gallon, Henri Chahinian, Alain De Caro, Robert Verger, René Laugier, Frédéric Carrière, Physiology of Gastrointestinal Lipolysis and Therapeutical Use of Lipases and Digestive Lipase Inhibitors Lipases and Phospholipases in Drug Development. pp. 195- 229 ,(2005) , 10.1002/3527601910.CH10
Jonathan K. Embleton, Colin W. Pouton, Structure and function of gastro-intestinal lipases Advanced Drug Delivery Reviews. ,vol. 25, pp. 15- 32 ,(1997) , 10.1016/S0169-409X(96)00488-7
Anna Elgart, Irina Cherniakov, Yanir Aldouby, Abraham J Domb, Amnon Hoffman, None, Improved Oral Bioavailability of BCS Class 2 Compounds by Self Nano-Emulsifying Drug Delivery Systems (SNEDDS): The Underlying Mechanisms for Amiodarone and Talinolol Pharmaceutical Research. ,vol. 30, pp. 3029- 3044 ,(2013) , 10.1007/S11095-013-1063-Y
Huiling Mu, René Holm, Anette Müllertz, Lipid-based formulations for oral administration of poorly water-soluble drugs. International Journal of Pharmaceutics. ,vol. 453, pp. 215- 224 ,(2013) , 10.1016/J.IJPHARM.2013.03.054
Peter G. Welling, Influence of food and diet on gastrointestinal drug absorption: a review. Journal of Pharmacokinetics and Biopharmaceutics. ,vol. 5, pp. 291- 334 ,(1977) , 10.1007/BF01061694
David J Hauss, None, Oral lipid-based formulations Advanced Drug Delivery Reviews. ,vol. 59, pp. 667- 676 ,(2007) , 10.1016/J.ADDR.2007.05.006
Christopher J.H. Porter, Colin W. Pouton, Jean F. Cuine, William N. Charman, Enhancing intestinal drug solubilisation using lipid-based delivery systems. Advanced Drug Delivery Reviews. ,vol. 60, pp. 673- 691 ,(2008) , 10.1016/J.ADDR.2007.10.014